Skip to main content

FDA recall, , Moderate risk

PhaseOne Antimicrobial Solution

PhaseOne Antimicrobial Solution has corrosion of its internal spring, which may cause discoloration and trace metals in the solution.

What happened

Oculus Technologies of Mexico, S.A. de V.C., of Zapopan, Mexico, is recalling PhaseOne Antimicrobial Solution because corrosion of the internal metallic spring within the sprayer component may result in visible discoloration and the presence of trace levels of metallic elements, including iron, chromium, and nickel, in the solution during use. The condition is caused by material incompatibility between the product solution and the stainless steel spring.

The recall affects 5904 units distributed in Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Kentucky, Michigan, Mississippi, North Carolina, New Jersey, New York, Tennessee, Texas, Utah, and Virginia. The company began the recall on April 27, 2026, and the FDA added it to its Enforcement Report on June 1, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the model number, UDI-DI and lot code listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. PhaseOne Antimicrobial Solution

    Model number
    • 15050
    UDI-DI
    • 00860009268616
    Lot code
    • 25G263

Recall details

Company began the recall
Company
Oculus Technologies of Mexico, S.A. de C.V.Zapopan, Mexico
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98959
Recall number
Z-2275-2026
Quantity recalled
5904 units

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)